Vanguard Capital Management
ISPC icon

Vanguard Capital Management’s iSpecimen ISPC Stock Holding History

Vanguard Capital Management’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82 Hold
31
– – ﹤0.01% 4090
2026
Q1 		$194 Buy
+31
New +$348 ﹤0.01% 4059

Other funds holding ISPC

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Vanguard Capital Management's ISPC Position: Q2 2026 in Review

Vanguard Capital Management held its iSpecimen (ISPC) position steady in Q2 2026 at 31 shares worth $82. The position accounts for ﹤0.01% of the portfolio, ranked #4090.

Vanguard Capital Management first reported a position in ISPC in Q1 2026 and has held it in 2 quarters since. The position peaked at $194 in Q1 2026. 8 funds tracked by Wall St. Rank hold ISPC as of Q2 2026.

  • Vanguard Capital Management held 31 shares of iSpecimen worth $82 as of Q2 2026.
  • Vanguard Capital Management left its iSpecimen share count unchanged in Q2 2026.
  • iSpecimen made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4090 holding.
  • Vanguard Capital Management first reported a position in iSpecimen in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's iSpecimen position peaked at $194 in Q1 2026.
  • 8 funds tracked by Wall St. Rank held iSpecimen as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.